The University of Kansas Cancer Center 2020 ASCO Highlights

https://www.kucancercenter.org/

 

2020 ASCO Update on Rectal Cancer: Should We Consider Total Neoadjuvant Therapy With mFOLFIRINOX a New Option for 1L Stage 3/4 Disease?

1,650 views
September 9, 2020
Comments 0
Login to view comments. Click here to Login